We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




More Specialists May Not Be Better for Neonates

By HospiMedica staff writers
Posted on 28 May 2002
A study has found that adding more hospital specialty services and doctors who are specialists does not always lead to better outcomes for newborns. More...
The study was published in the May 16, 2002, issue of The New England Journal of Medicine.

US researchers found wide regional differences in the availability of newborn specialists and intensive care nursery beds that do not correlate well with improved neonate survival. This finding has led them to reassess the allocation of resources designed to improve newborn health. The basic determinant of neonatal outcomes is whether a baby is born premature, a factor not influenced by neonatal specialists. When a sick baby is born, survival may be more related to the organization and use of existing resources than to the number of doctors or other resources, the investigators found.

The research team studied almost 3.9 million infants born in 1995 with a weight of at least 500 grams. The overall mortality rate was 3.4% per 1,000 live births. Different US regions were grouped according to the supply of neonatologists per newborn: very low, low, medium, high, and very high. The investigators found no difference in the mortality once the supply of neonatologists exceeded the "low” supply category. While the death rate was 7% lower in regions with 4.3 neonatologists per 10,000 births than in those with 2.7 neonatologists, further increases in neonatologists made no difference in the death rate. The team also looked at the supply of neonatal intensive care beds and found no reduction in mortality as the number of beds increased.

"A few regions of the country appear to be underserved in neonatologists, in that neonatal mortality rates are worse in the areas of very lowest supply,” said David Goodman, M.D., associate professor of pediatrics at Dartmouth Medical School (Hanover, NH, USA). "However, beyond the numbers found in the low-supply areas, there are no further benefits of more neonatologists.”

In an editorial in the same issue, Kevin Grumback of the University of California, San Francisco (USA), says these results represent how a market-driven health-care system lacking public planning can produce too much of a good thing.



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.